Celldex Therapeutics (CLDX) Reports Q4 Loss, Tops Revenue Estimates
Celldex Therapeutics (CLDX - Free Report) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.76....
Celldex Therapeutics (CLDX - Free Report) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.76....